Ian Taylor - Mar 1, 2023 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Matthew Batters, as attorney-in-fact for Ian Taylor
Stock symbol
ARVN
Transactions as of
Mar 1, 2023
Transactions value $
-$31,036
Form type
4
Date filed
3/3/2023, 08:51 PM
Previous filing
Feb 24, 2023
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Options Exercise +2.69K +2.68% 103K Mar 1, 2023 Direct F1
transaction ARVN Common Stock Sale -$31K -1.05K -1.02% $29.53 102K Mar 1, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Restricted Stock Units Options Exercise $0 -2.69K -100% $0.00* 0 Mar 1, 2023 Common Stock 2.69K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2 This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3 The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at a price of $29.53.
F4 On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.